NovoCure Limited (NASDAQ:NVCR) Q1 2026 Earnings Call Transcript April 30, 2026
NovoCure Limited misses on earnings expectations. Reported EPS is $-0.62 EPS, expectations were $-0.51219.
Operator: Good day, and thank you for standing by. Welcome to the NovoCure’s Q1 2026 Earnings Call. [Operator Instructions] Please be advised that today’s conference is being recorded. I would now like to hand the conference over to your first speaker today, Adam Daney. Please go ahead.
Adam Daney: Good...
